FDEV - ETF AI Analysis
Top Page
Fidelity International Multifactor ETF (FDEV)
Rating:64Neutral
Price Target:―
Positive Factors
Strong Energy and Utility Holdings
Several of the largest positions in energy and utilities have shown strong performance this year, helping support the ETF’s overall returns.
Broad International Diversification
The fund spreads its investments across many countries such as Japan, the UK, the U.S., Canada, and several European markets, which helps reduce reliance on any single economy.
Low Expense Ratio
The ETF charges a relatively low fee, which means more of the fund’s returns can stay in investors’ pockets over time.
Negative Factors
Mixed Performance Among Top Holdings
While many top positions are performing well, at least one major holding has been weak this year, slightly dragging on overall results.
Limited Technology Exposure
The fund has only a small allocation to the technology sector, which could cause it to miss out if tech stocks continue to be strong drivers of market gains.
Short-Term Performance Bump With Recent Soft Patch
The ETF’s year-to-date and one-month returns are positive, but its recent three-month performance has been slightly negative, showing that results can be uneven over shorter periods.
FDEV vs. SPDR S&P 500 ETF (SPY)
AUM290.36M
RegionDeveloped Markets
Expense Ratio0.18%
Beta0.48
IssuerFidelity
Inception DateFeb 26, 2019
Dividend Yield2.91%
Asset ClassEquity
Index TrackedFidelity International Multifactor Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume28,859
30 Day Avg. Volume34,005
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
44.60Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering195
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FDEV Summary
Fidelity International Multifactor ETF (FDEV) is a fund that tracks the Fidelity International Multifactor Index, giving you broad exposure to stocks from many countries outside the U.S., including Japan, the UK, and Canada. It holds companies across many industries, such as energy, financials, and health care, with well-known names like Shell and AstraZeneca. Investors might consider FDEV to diversify their portfolio globally and spread risk across different regions and sectors. However, because it invests in international stocks, its value can go up and down with global markets and currency changes.
How much will it cost me?The Fidelity International Multifactor ETF (Ticker: FDEV) has an expense ratio of 0.19%, which means you’ll pay $1.90 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking a specific index rather than relying on active stock selection.
What would affect this ETF?FDEV's focus on developed markets outside the U.S. and its exposure to sectors like financials, materials, and utilities could benefit from global economic growth, infrastructure spending, and stable demand for essential services. However, challenges such as rising interest rates, regulatory changes in international markets, or economic slowdowns in key regions could negatively impact its performance. Additionally, sector-specific risks, like fluctuating commodity prices for materials or energy, may influence returns.
FDEV Top 10 Holdings
FDEV’s story is driven by a mix of defensive giants and a few high-octane names. ASML is the clear engine here, with its surging chip exposure giving the fund a strong tech tailwind despite tech being a small slice overall. Roche, Novartis, and Shell are steadily pulling their weight, offering a more defensive backbone from health care and energy. On the softer side, AstraZeneca has been losing steam and NEXON has been lagging, acting as mild brakes. The fund is firmly ex‑U.S., with a broad spread across Europe and Asia rather than a single-country bet.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Daito Construction | 1.79% | $5.21M | ¥1.12T | -5.72% | 73 Outperform | |
| Klepierre (ex Compagnie Fonciere Klepierre) | 1.67% | $4.85M | €10.43B | 11.88% | 72 Outperform | |
| Hongkong Land Holdings | 1.58% | $4.61M | $18.24B | 0.00% | ― | |
| Roche Holding AG | 1.54% | $4.49M | $348.56B | 29.76% | 73 Outperform | |
| Shell (UK) | 1.53% | $4.44M | £199.58B | 31.38% | 73 Outperform | |
| Novartis AG | 1.48% | $4.31M | CHF229.66B | 9.54% | 80 Outperform | |
| ASML Holding NV | 1.43% | $4.17M | €573.13B | 120.43% | 76 Outperform | |
| AstraZeneca | 1.32% | $3.84M | $252.93B | -0.84% | 80 Outperform | |
| NEXON Co | 1.30% | $3.78M | ¥2.32T | -13.39% | 76 Outperform | |
| TotalEnergies SE | 1.29% | $3.75M | €172.55B | 46.31% | 78 Outperform |
FDEV Technical Analysis
Neutral
―
Price Trends
37.13
Positive
36.50
Positive
35.76
Positive
Market Momentum
0.22
Positive
50.06
Neutral
46.67
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FDEV, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 37.90, equal to the 50-day MA of 37.13, and equal to the 200-day MA of 35.76, indicating a neutral trend. The MACD of 0.22 indicates Positive momentum. The RSI at 50.06 is Neutral, neither overbought nor oversold. The STOCH value of 46.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FDEV.
FDEV Peer Comparison
Comparison Results
Performance Comparison
FDEV
Fidelity International Multifactor ETF
37.69
5.24
16.15%
FYLD
Cambria Foreign Shareholder Yield ETF
―
―
―
TLTD
FlexShares Morningstar Developed Markets ex-US Factor Tilt
―
―
―
TXUE
Thornburg International Equity ETF
―
―
―
MFDX
PIMCO RAFI Dynamic Multi-Factor International Equity ETF
―
―
―
AVSD
Avantis Responsible International Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents